MiR-1266 suppresses the growth and metastasis of prostate cancer via targeting PRMT5
- Type
- Retraction
- Notice date
- 7/15/2021 0:00
- Journal
- European Review for Medical and Pharmacological Sciences
- Publisher
- Verduci Editore
- Notice DOI
- 10.26355/eurrev_202107_26223
- Original paper DOI
- 10.26355/eurrev_201908_18525